GlassScriptPhysician profile
Ido S Preis
NPI 1477729473
$1,116.61
in general payments reported to CMS, 2019-2025
10 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $40.03 · 2021: $292 · 2022: $166 · 2023: $91.99 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $376.24 | 2020-2022 | |
| Edwards Lifesciences Corporation | $179.41 | 2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $172.29 | 2019-2023 | Watchman Access System |
| Heartflow, INC. | $149.36 | 2025 | |
| Novartis Pharmaceuticals Corporation | $117.21 | 2019 | |
| Abbott Laboratories | $27.93 | 2021 | |
| Philips North America LLC | $26.72 | 2022 | |
| Janssen Pharmaceuticals, INC | $24.41 | 2022 | |
| Ge Healthcare | $24.28 | 2022 | |
| Lantheus Medical Imaging, INC. | $18.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ido Preis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.